Simplex Trading
CRBP icon

Simplex Trading’s Corbus Pharmaceuticals CRBP Stock Holding History

Simplex Trading’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$496K Buy
+52,836
New +$445K ﹤0.01% 3272
2025
Q4 		– Sell
-17,950
Closed -$227K – 8773
2025
Q3 		$227K Buy
17,950
+15,131
+537% +$144K ﹤0.01% 4781
2025
Q2 		$19K Sell
2,819
-3,054
-52% -$22.2K ﹤0.01% 6799
2025
Q1 		$31K Buy
5,873
+4,974
+553% +$43.9K ﹤0.01% 6211
2024
Q4 		$10K Buy
+899
New +$15.1K ﹤0.01% 7177
2024
Q3 		– Sell
-1,727
Closed -$88.4K – 8629
2024
Q2 		$78K Sell
1,727
-263
-13% -$11.1K ﹤0.01% 5626
2024
Q1 		$78K Buy
+1,990
New +$49.1K ﹤0.01% 5841
2022
Q1 		– Sell
-998
Closed -$13.2K – 10515
2021
Q4 		$18K Sell
998
-2,262
-69% -$61.3K ﹤0.01% 8460
2021
Q3 		$177K Sell
3,260
-521
-14% -$20.5K ﹤0.01% 5793
2021
Q2 		$207K Buy
3,781
+2,924
+341% +$162K ﹤0.01% 5626
2021
Q1 		$50K Sell
857
-1,441
-63% -$94.7K ﹤0.01% 6613
2020
Q4 		$86K Sell
2,298
-6,736
-75% -$252K ﹤0.01% 5593
2020
Q3 		$487K Buy
9,034
+5,879
+186% +$1.06M ﹤0.01% 3032
2020
Q2 		$794K Buy
3,155
+2,959
+1,510% +$598K ﹤0.01% 2359
2020
Q1 		$30K Sell
196
-481
-71% -$81.3K ﹤0.01% 5619
2019
Q4 		$110K Buy
+677
New +$100K ﹤0.01% 4422
2019
Q1 		– Sell
-632
Closed -$139K – 7209
2018
Q4 		$110K Sell
632
-149
-19% -$29.7K ﹤0.01% 3775
2018
Q3 		$176K Buy
+781
New +$126K ﹤0.01% 3789
2018
Q2 		– Sell
-49
Closed -$8.9K – 7419
2018
Q1 		$9K Sell
49
-518
-91% -$116K ﹤0.01% 4105
2017
Q4 		$120K Buy
+567
New +$121K 0.01% 1658
2017
Q3 		– Sell
-782
Closed -$153K – 5978
2017
Q2 		$147K Buy
+782
New +$153K 0.01% 1435
2017
Q1 		– Sell
-273
Closed -$67K – 6221
2016
Q4 		$69K Buy
273
+134
+96% +$30.7K ﹤0.01% 1840
2016
Q3 		$28K Buy
+139
New +$17.3K ﹤0.01% 2623

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Simplex Trading's CRBP Position: Q1 2026 in Review

Simplex Trading opened a new position in Corbus Pharmaceuticals (CRBP) in Q1 2026: 52,836 shares worth $496K. The stake represents ﹤0.01% of the portfolio and ranks #3272 among its holdings. This is a return to the name: Simplex Trading previously reported a position in CRBP as recently as Q3 2025.

Simplex Trading first reported a position in CRBP in Q3 2016 and has held it in 23 quarters since. The position peaked at $794K in Q2 2020. 107 funds tracked by Wall St. Rank hold CRBP as of Q1 2026.

  • Simplex Trading held 52,836 shares of Corbus Pharmaceuticals worth $496K as of Q1 2026.
  • Corbus Pharmaceuticals was a new Simplex Trading position in Q1 2026.
  • Corbus Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #3272 holding.
  • Simplex Trading first reported a position in Corbus Pharmaceuticals in Q3 2016 and has held it in 23 quarters since.
  • Simplex Trading's Corbus Pharmaceuticals position peaked at $794K in Q2 2020.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.